# NHS National Pharmaceuticals Transition 2022\_2

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £58,707,390
- Published: 19 July 2022
- Planned start: 1 December 2022
- Planned end: 31 May 2024
- Stage: open_tender
- Procurement category: goods
- Notice ID: 26487991-3c18-4fae-9686-311c8f48460e-555872
- OCID: ocds-b5fd17-d6598323-ebe9-499b-a63e-bbd90ec94b18

## Description

Invitation to offer for NHS National Pharmaceuticals Transition 2022\_2 Offer reference number: CM/PHG/22/5655 Period of framework agreement: Dates detailed below, with an option or options to extend \(at the discretion of the Authority\) up to maximum contract length of 48 months\. Potential periods of call-offs under the framework agreement: Transition: CESW: 01/12/2022 to 30/09/2023 \(10 months\) LSNE: 01/12/2022 to 31/05/2024 \(18 months\) NWLN: 01/12/2022 to 31/05/2023 \(6 months\)

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/26487991-3c18-4fae-9686-311c8f48460e-555872)